{"id":"https://openalex.org/W3083068511","doi":"https://doi.org/10.1158/1538-7445.am2020-3310","title":"Abstract 3310: Resolving the heterogeneity of human circulating innate lymphoid cells via simultaneous, high-dimensional analysis of protein and gene expression","display_name":"Abstract 3310: Resolving the heterogeneity of human circulating innate lymphoid cells via simultaneous, high-dimensional analysis of protein and gene expression","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083068511","doi":"https://doi.org/10.1158/1538-7445.am2020-3310","mag":"3083068511"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-3310","doi":"https://doi.org/10.1158/1538-7445.am2020-3310","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3310","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000121750","display_name":"Aaron J. Tyznik","orcid":"https://orcid.org/0000-0002-9120-8530","observed_orcids":["https://orcid.org/0000-0002-9120-8530"]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron J. Tyznik","raw_affiliation_strings":["1BD Biosciences, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BD Biosciences, San Diego, CA;","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113669036","display_name":"Mirko Corselli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mirko Corselli","raw_affiliation_strings":["1BD Biosciences, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BD Biosciences, San Diego, CA;","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071995803","display_name":"Gisle V. Baracho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gisle V. Baracho","raw_affiliation_strings":["1BD Biosciences, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BD Biosciences, San Diego, CA;","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046755433","display_name":"Chip Lomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chip Lomas","raw_affiliation_strings":["2BD Biosciences, San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2BD Biosciences, San Jose, CA","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110588905","display_name":"Silin Sa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Silin Sa","raw_affiliation_strings":["2BD Biosciences, San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2BD Biosciences, San Jose, CA","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070942966","display_name":"Stephanie Widmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Widmann","raw_affiliation_strings":["1BD Biosciences, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BD Biosciences, San Diego, CA;","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048066667","display_name":"Suraj Saksena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suraj Saksena","raw_affiliation_strings":["2BD Biosciences, San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2BD Biosciences, San Jose, CA","institution_ids":["https://openalex.org/I4210116987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045150910","display_name":"Smita Ghanekar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116987","display_name":"BD Biosciences (United States)","ror":"https://ror.org/02h9td068","country_code":"US","type":"company","lineage":["https://openalex.org/I146461966","https://openalex.org/I4210116987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smita Ghanekar","raw_affiliation_strings":["2BD Biosciences, San Jose, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2BD Biosciences, San Jose, CA","institution_ids":["https://openalex.org/I4210116987"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210116987"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"3310","last_page":"3310"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11289","display_name":"Single-cell and spatial transcriptomics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/innate-lymphoid-cells","display_name":"innate lymphoid cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/group-2-innate-lymphoid-cells","display_name":"ILC2","score":0.8709999918937683},{"id":"https://openalex.org/keywords/ilc3","display_name":"ILC3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cd127","display_name":"CD127","score":0.7789999842643738},{"id":"https://openalex.org/keywords/c-kit","display_name":"CD117","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immunotherapy-targets","display_name":"immunotherapy targets","score":0.6349999904632568},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.6510000228881836},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C47742525","wikidata":"https://www.wikidata.org/wiki/Q13418826","display_name":"Innate lymphoid cell","level":4,"score":0.854810357093811},{"id":"https://openalex.org/C123982805","wikidata":"https://www.wikidata.org/wiki/Q6046964","display_name":"Interleukin-7 receptor","level":5,"score":0.7259135842323303},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6659470796585083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6334735751152039},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5633108615875244},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5119763612747192},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4332835078239441},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.41447779536247253},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.35970672965049744},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3488125801086426},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.20846831798553467},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11034893989562988},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-3310","doi":"https://doi.org/10.1158/1538-7445.am2020-3310","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3310","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313382862","https://openalex.org/W3206580789","https://openalex.org/W2562858382","https://openalex.org/W4308595111","https://openalex.org/W3109111319","https://openalex.org/W2775272419","https://openalex.org/W2768801250","https://openalex.org/W2952128354","https://openalex.org/W7129211345","https://openalex.org/W3012871917"],"abstract_inverted_index":{"Abstract":[0],"Cancer":[1,465,477],"treatment":[2],"has":[3,44,167],"been":[4,45,111,136],"revolutionized":[5],"with":[6],"the":[7,50,80,104,183,203,225,262,291,319,357,363,369,393,436,457,461],"development":[8],"of":[9,29,35,53,75,82,95,128,148,154,175,185,205,255,279,293,307,311,321,338,359,368,401,438,448,456,460],"immunomodulatory":[10],"therapies.":[11],"These":[12,325],"therapies":[13],"have":[14,110,135],"primarily":[15],"focused":[16],"on":[17,140],"enhancing":[18],"T-cell":[19],"responses:":[20],"whether":[21],"it":[22],"is":[23,89,187],"unleashing":[24],"T":[25,40],"cells":[26,56,69,84,156,443],"through":[27,157],"blockade":[28],"regulatory":[30],"checkpoint":[31],"inhibitors":[32],"or":[33,163,313,385,406],"generation":[34],"chimeric":[36],"antigen":[37],"receptor":[38],"(CAR)":[39],"cells.":[41,62],"However,":[42],"there":[43,88],"recent":[46],"interest":[47],"in":[48,118,274,383],"harnessing":[49],"immunotherapeutic":[51],"potential":[52,81],"other":[54],"cytotoxic":[55],"such":[57],"as":[58,103,288,290],"Natural":[59],"Killer":[60],"(NK)":[61],"Similar":[63],"to":[64,113,200,251,276,329,373],"NK":[65],"cells,":[66],"innate":[67,441],"lymphoid":[68,442],"(ILCs)":[70],"may":[71],"offer":[72],"another":[73],"target":[74],"these":[76,83,96,155,322],"immunotherapy":[77],"approaches.":[78],"Before":[79],"can":[85],"be":[86,374],"realized,":[87],"a":[90,115,169,197,242,308],"need":[91],"for":[92,233,335,381,464],"better":[93],"understanding":[94],"recently":[97],"described":[98],"cell":[99,229],"populations.":[100],"ILCs":[101,130,176,186,211],"act":[102],"immune":[105],"system's":[106],"first":[107],"responders":[108],"and":[109,123,133,143,172,180,190,231,241,258,270,281,350,365,397,404,450,471],"shown":[112],"play":[114],"key":[116],"role":[117],"tissue":[119],"homeostasis,":[120],"chronic":[121],"inflammation":[122],"cancer.":[124],"Three":[125],"main":[126],"groups":[127],"non-cytotoxic":[129],"(ILC1,":[131],"ILC2":[132],"ILC3)":[134],"broadly":[137],"defined":[138,351],"based":[139],"developmental":[141],"trajectories":[142],"function,":[144],"driven":[145],"by":[146,221],"expression":[147,272,278,306,452],"specific":[149],"transcription":[150],"factors.":[151],"Deeper":[152],"characterization":[153],"either":[158],"high":[159],"parameter":[160],"protein":[161,269,449],"analysis":[162,273,337,355,447],"single-cell":[164,235],"RNA":[165],"sequencing":[166],"revealed":[168],"more":[170],"complex":[171],"heterogeneous":[173],"nature":[174],"across":[177,346],"different":[178,339],"tissues":[179],"donors.":[181,341],"Therefore,":[182],"identity":[184],"still":[188],"elusive":[189],"controversial.":[191],"In":[192],"this":[193],"study,":[194],"we":[195],"developed":[196],"comprehensive":[198],"approach":[199,301],"further":[201],"refine":[202],"signatures":[204,292],"human":[206,439],"circulating":[207,440],"ILC":[208,286,323,342],"subsets.":[209,324],"Total":[210],"(Lineage-":[212],"CD127+":[213],"cells)":[214],"were":[215,249,327,348],"enriched":[216],"from":[217],"4":[218],"normal":[219],"donors":[220,347],"flow":[222,332],"sorting":[223],"using":[224,261,352],"BD":[226,244,263,394],"FACSAria\u2122":[227],"Fusion":[228],"sorter":[230],"processed":[232],"downstream":[234],"multiomic":[236,360],"characterization.":[237],"BD\u00ae":[238],"AbSeq":[239],"reagents":[240],"targeted":[243],"Rhapsody\u2122":[245,264],"Immune":[246],"Response":[247],"Panel":[248],"used":[250,328],"enable":[252,318],"simultaneous":[253],"detection":[254],"42":[256],"proteins":[257,312],"399":[259],"genes":[260,316],"Single-Cell":[265],"Analysis":[266],"System.":[267],"Differential":[268],"gene":[271,451],"addition":[275],"combinatorial":[277],"CD294":[280],"CD117":[282],"confirmed":[283],"3":[284],"conventional":[285],"populations":[287],"well":[289],"three":[294],"distinct":[295],"subsets":[296,343,371],"within":[297],"ILC1.":[298],"This":[299],"discovery":[300],"provided":[302],"information":[303],"about":[304],"relative":[305],"small":[309],"selection":[310],"surface":[314],"marker-coding":[315],"that":[317],"discrimination":[320],"data":[326],"design":[330],"high-parameter":[331],"cytometry":[333],"panels":[334],"high-throughput":[336],"healthy":[340],"differentially":[344],"distributed":[345],"detected":[349],"unsupervised":[353],"computational":[354],"confirming":[356],"result":[358],"analysis,":[361],"while":[362],"functional":[364],"biological":[366],"relevance":[367],"identified":[370],"remains":[372],"assessed.":[375],"For":[376],"Research":[377,466],"Use":[378],"Only.":[379],"Not":[380],"use":[382],"diagnostic":[384],"therapeutic":[386],"procedures.":[387],"Class":[388],"1":[389],"laser":[390],"product.":[391],"BD,":[392],"Logo,":[395],"FACSymphony":[396],"Rhapsody":[398],"are":[399],"trademarks":[400],"Becton,":[402],"Dickinson":[403],"Company":[405],"its":[407],"affiliates.":[408],"\u00a9":[409],"2019":[410],"BD.":[411],"All":[412],"rights":[413],"reserved.":[414],"Citation":[415],"Format:":[416],"Aaron":[417],"J.":[418],"Tyznik,":[419],"Mirko":[420],"Corselli,":[421],"Gisle":[422],"V.":[423],"Baracho,":[424],"Chip":[425],"Lomas,":[426],"Silin":[427],"Sa,":[428],"Stephanie":[429],"Widmann,":[430],"Suraj":[431],"Saksena,":[432],"Smita":[433],"Ghanekar.":[434],"Resolving":[435],"heterogeneity":[437],"via":[444],"simultaneous,":[445],"high-dimensional":[446],"[abstract].":[453],"In:":[454],"Proceedings":[455],"Annual":[458],"Meeting":[459],"American":[462],"Association":[463],"2020;":[467],"2020":[468],"Apr":[469],"27-28":[470],"Jun":[472],"22-24.":[473],"Philadelphia":[474],"(PA):":[475],"AACR;":[476],"Res":[478],"2020;80(16":[479],"Suppl):Abstract":[480],"nr":[481],"3310.":[482]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2020-09-11T00:00:00"}